Cargando…
Update on Melasma—Part I: Pathogenesis
Melasma is a multifactorial dyschromia that results from exposure to external factors (such as solar radiation) and hormonal factors (such as sex hormones and pregnancy), as well as skin inflammation (such as contact dermatitis and esthetic procedures), in genetically predisposed individuals. Beyond...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464278/ https://www.ncbi.nlm.nih.gov/pubmed/35904706 http://dx.doi.org/10.1007/s13555-022-00779-x |
_version_ | 1784787547943075840 |
---|---|
author | Espósito, Ana Cláudia C. Cassiano, Daniel P. da Silva, Carolina N. Lima, Paula B. Dias, Joana A. F. Hassun, Karime Bagatin, Ediléia Miot, Luciane D. B. Miot, Hélio Amante |
author_facet | Espósito, Ana Cláudia C. Cassiano, Daniel P. da Silva, Carolina N. Lima, Paula B. Dias, Joana A. F. Hassun, Karime Bagatin, Ediléia Miot, Luciane D. B. Miot, Hélio Amante |
author_sort | Espósito, Ana Cláudia C. |
collection | PubMed |
description | Melasma is a multifactorial dyschromia that results from exposure to external factors (such as solar radiation) and hormonal factors (such as sex hormones and pregnancy), as well as skin inflammation (such as contact dermatitis and esthetic procedures), in genetically predisposed individuals. Beyond hyperfunctional melanocytes, skin with melasma exhibits a series of structural and functional alterations in the epidermis, basement membrane, and upper dermis that interact to elicit and sustain a focal hypermelanogenic phenotype. Evolution in the knowledge of the genetic basis of melasma and the cutaneous response to solar radiation, as well as the roles of endocrine factors, antioxidant system, endothelium proliferation, fibroblast senescence, mast cell degranulation, autophagy deficits of the melanocyte, and the paracrine regulation of melanogenesis, will lead to the development of new treatments and preventive strategies. This review presents current knowledge on these aspects of the pathogenesis of melasma and discusses the effects of specific treatments and future research on these issues. |
format | Online Article Text |
id | pubmed-9464278 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-94642782022-09-12 Update on Melasma—Part I: Pathogenesis Espósito, Ana Cláudia C. Cassiano, Daniel P. da Silva, Carolina N. Lima, Paula B. Dias, Joana A. F. Hassun, Karime Bagatin, Ediléia Miot, Luciane D. B. Miot, Hélio Amante Dermatol Ther (Heidelb) Review Melasma is a multifactorial dyschromia that results from exposure to external factors (such as solar radiation) and hormonal factors (such as sex hormones and pregnancy), as well as skin inflammation (such as contact dermatitis and esthetic procedures), in genetically predisposed individuals. Beyond hyperfunctional melanocytes, skin with melasma exhibits a series of structural and functional alterations in the epidermis, basement membrane, and upper dermis that interact to elicit and sustain a focal hypermelanogenic phenotype. Evolution in the knowledge of the genetic basis of melasma and the cutaneous response to solar radiation, as well as the roles of endocrine factors, antioxidant system, endothelium proliferation, fibroblast senescence, mast cell degranulation, autophagy deficits of the melanocyte, and the paracrine regulation of melanogenesis, will lead to the development of new treatments and preventive strategies. This review presents current knowledge on these aspects of the pathogenesis of melasma and discusses the effects of specific treatments and future research on these issues. Springer Healthcare 2022-07-29 /pmc/articles/PMC9464278/ /pubmed/35904706 http://dx.doi.org/10.1007/s13555-022-00779-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Review Espósito, Ana Cláudia C. Cassiano, Daniel P. da Silva, Carolina N. Lima, Paula B. Dias, Joana A. F. Hassun, Karime Bagatin, Ediléia Miot, Luciane D. B. Miot, Hélio Amante Update on Melasma—Part I: Pathogenesis |
title | Update on Melasma—Part I: Pathogenesis |
title_full | Update on Melasma—Part I: Pathogenesis |
title_fullStr | Update on Melasma—Part I: Pathogenesis |
title_full_unstemmed | Update on Melasma—Part I: Pathogenesis |
title_short | Update on Melasma—Part I: Pathogenesis |
title_sort | update on melasma—part i: pathogenesis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464278/ https://www.ncbi.nlm.nih.gov/pubmed/35904706 http://dx.doi.org/10.1007/s13555-022-00779-x |
work_keys_str_mv | AT espositoanaclaudiac updateonmelasmapartipathogenesis AT cassianodanielp updateonmelasmapartipathogenesis AT dasilvacarolinan updateonmelasmapartipathogenesis AT limapaulab updateonmelasmapartipathogenesis AT diasjoanaaf updateonmelasmapartipathogenesis AT hassunkarime updateonmelasmapartipathogenesis AT bagatinedileia updateonmelasmapartipathogenesis AT miotlucianedb updateonmelasmapartipathogenesis AT miothelioamante updateonmelasmapartipathogenesis |